Meeting with an official delegation from Ukraine
Integrum, which recently became a member of Swecare, was on hand when an official delegation from Ukraine visited Stockholm in mid-October.
Published
Integrum Investor News
97.9 percent of implants functioning after one year in war veterans
A new study of 49 Ukrainian war veterans treated with the OPRA Implant System has been published in International Orthopaedics.
Published
Martin Hillsten on the directed share issue
Integrum’s CEO Martin Hillsten sees that increased financial stability will enable the company to more quickly seize the opportunities now opening up in both the US and Ukraine.
Published
Integrum has completed a directed share issue
The company will receive approximately SEK 22.9 million before deduction of transaction costs. Investors include Cicero Fonder, Nowo Fund Management, Curam Holding, Maria Anderkvist, Förvaltnings AB Grötlingboudd,...
Published
First U.S. patient implanted with e-OPRA in clinical study
A clinical study led by Shirley Ryan AbilityLab has reached its first milestone, with the first U.S. patient implanted with e-OPRA™ – a key step in the development of implantable intelligent bionics.
Published
Ukrainian state funds pilot program for osseointegration
"We look forward to continuing to support Ukrainian hospitals and surgeons in building capacity and expertise in this field," says Dr. Rickard Brånemark.
Published
Integrum's Q1 report
Read Integrum’s interim report for the first quarter of the company’s financial year.
Published
Watch Integrum's Q1 presentation
On Thursday September 3rd 2026, CEO Martin Hillsten and CFO Louise Wåhlin presented the company’s results for the first quarter of 2026/27. Watch the presentation here.
Published
From transformation to acceleration
Comment by: Martin Hillsten
Afyri acclerates the development within bionics
The subsidiary Afyri will unlock the potential within e-OPRA and create an AI based platform for the interface between human and prosthesis.
Published
Rickard Brånemark writes in Nordic Life Science on Ukraine
Rickard Brånemark, chief medical and scientific officer of Integrum, has written a commentary for Nordic Life Science about his experiences from the war.
Published